Lexeo Therapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

571.49M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	654.00K	-1.00M	-60.53%
Dec 31, 2021	1.66M	1.14M	219.59%
Dec 31, 2020	518.48K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	435.16B
Johnson & Johnson	92.15B
Merck & Co.	64.24B
AbbVie	59.64B
Eli Lilly and Company	59.42B
AstraZeneca	56.50B
Novartis AG	56.37B
Novo Nordisk	49.58B

Revenue Rankings

LXEO News

18 hours ago - Lexeo Therapeutics: Behind The Rebound - Seeking Alpha
2 days ago - Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire
17 days ago - Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters' Option to Purchase Additional Shares in the Public Offering - GlobeNewsWire
21 days ago - Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement - GlobeNewsWire
21 days ago - Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
4 weeks ago - Lexeo: Maintaining Buy Rating Based On FDA Accelerated Approval Feedback - Seeking Alpha
4 weeks ago - Lexeo Therapeutics, Inc. - Special Call - Seeking Alpha
4 weeks ago - Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy - GlobeNewsWire

More News